Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

NCT03760523 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Toxicity -Two DLT events occurred

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Minnelide

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]